130 related articles for article (PubMed ID: 20653104)
61. Immunization with Leishmania vaccine-alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model.
Mutiso JM; Macharia JC; Gicheru MM
Scand J Immunol; 2012 Nov; 76(5):471-7. PubMed ID: 22862788
[TBL] [Abstract][Full Text] [Related]
62. A novel DBL-domain of the P. falciparum 332 molecule possibly involved in erythrocyte adhesion.
Moll K; Chêne A; Ribacke U; Kaneko O; Nilsson S; Winter G; Haeggström M; Pan W; Berzins K; Wahlgren M; Chen Q
PLoS One; 2007 May; 2(5):e477. PubMed ID: 17534427
[TBL] [Abstract][Full Text] [Related]
63. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9.
Coban C; Igari Y; Yagi M; Reimer T; Koyama S; Aoshi T; Ohata K; Tsukui T; Takeshita F; Sakurai K; Ikegami T; Nakagawa A; Horii T; Nuñez G; Ishii KJ; Akira S
Cell Host Microbe; 2010 Jan; 7(1):50-61. PubMed ID: 20114028
[TBL] [Abstract][Full Text] [Related]
64. Preclinical evaluation of a chimeric malaria vaccine candidate in Montanide ISA 720: immunogenicity and safety in rhesus macaques.
Langermans JA; Hensmann M; van Gijlswiik M; Zhang D; Pan W; Giersing BK; Locke E; Dubovsk F; Wittes J; Thomas AW
Hum Vaccin; 2006; 2(5):222-6. PubMed ID: 17035731
[TBL] [Abstract][Full Text] [Related]
65. Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332.
Andersson C; Vasconcelos NM; Sievertzon M; Haddad D; Liljeqvist S; Berglund P; Liljeström P; Ahlborg N; Ståhl S; Berzins K
Scand J Immunol; 2001; 54(1-2):117-24. PubMed ID: 11439157
[TBL] [Abstract][Full Text] [Related]
66. Oil-based adjuvants delivered intradermally induce high primary IgG2 immune response in swine.
Oreskovic Z; Kudlackova H; Krejci J; Nechvatalova K; Faldyna M
Res Vet Sci; 2017 Oct; 114():41-43. PubMed ID: 28319826
[TBL] [Abstract][Full Text] [Related]
67. Production of guinea pig IgG1 homocytotropic antibodies to hapten-conjugated homologous serum albumin with different adjuvant combinations.
Wong DT; Barbaro JF
Int Arch Allergy Appl Immunol; 1976; 50(2):155-63. PubMed ID: 1245353
[TBL] [Abstract][Full Text] [Related]
68. Induction of humoral immune response against PfMSP-1(19) and PvMSP-1(19) using gold nanoparticles along with alum.
Parween S; Gupta PK; Chauhan VS
Vaccine; 2011 Mar; 29(13):2451-60. PubMed ID: 21288801
[TBL] [Abstract][Full Text] [Related]
69. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66.
Carcaboso AM; Hernández RM; Igartua M; Gascón AR; Rosas JE; Patarroyo ME; Pedraz JL
Int J Pharm; 2003 Jul; 260(2):273-82. PubMed ID: 12842346
[TBL] [Abstract][Full Text] [Related]
70. Effects of various adjuvants and a viral infection on the antibody specificity toward native or cryptic epitopes of a protein antigen.
Gómez KA; Longhi SA; Marino VJ; Mathieu PA; Loureiro ME; Coutelier JP; Roguin LP; Retegui LA
Scand J Immunol; 2003 Feb; 57(2):144-50. PubMed ID: 12588660
[TBL] [Abstract][Full Text] [Related]
71. Characterization of the Duffy-Binding-Like Domain of Plasmodium falciparum Blood-Stage Antigen 332.
Nilsson S; Moll K; Angeletti D; Albrecht L; Kursula I; Jiang N; Sun X; Berzins K; Wahlgren M; Chen Q
Malar Res Treat; 2011; 2011():671439. PubMed ID: 22312570
[TBL] [Abstract][Full Text] [Related]
72. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants.
Stills HF
ILAR J; 2005; 46(3):280-93. PubMed ID: 15953835
[TBL] [Abstract][Full Text] [Related]
73. Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.
Lawrence GW; Saul A; Giddy AJ; Kemp R; Pye D
Vaccine; 1997 Feb; 15(2):176-8. PubMed ID: 9066035
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses.
Rajananthanan P; Attard GS; Sheikh NA; Morrow WJ
Vaccine; 1999 Feb; 17(7-8):715-30. PubMed ID: 10067677
[TBL] [Abstract][Full Text] [Related]
75. Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs.
Zhang J; Wang P; Li Z; Xie Y; Jin N; Zhang H; Lu H; Han J
BMC Vet Res; 2024 Mar; 20(1):82. PubMed ID: 38448902
[TBL] [Abstract][Full Text] [Related]
76. Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge.
Klingström J; Maljkovic I; Zuber B; Rollman E; Kjerrström A; Lundkvist A
Vaccine; 2004 Sep; 22(29-30):4029-34. PubMed ID: 15364453
[TBL] [Abstract][Full Text] [Related]
77. CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE).
Makinen SR; Zhu Q; Davis HL; Weeratna RD
Int Immunol; 2016 Sep; 28(9):453-61. PubMed ID: 27055469
[TBL] [Abstract][Full Text] [Related]
78. Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control.
Brewer JM; Alexander J
Vaccine; 1994 May; 12(7):613-9. PubMed ID: 8085378
[TBL] [Abstract][Full Text] [Related]
79. Breaking the non-responsiveness of C57BL/6 mice to the malarial antigen EB200--the role of carrier and adjuvant molecules.
Rahman QK; Berzins K; López MC; Fernández C
Scand J Immunol; 2003 Oct; 58(4):395-403. PubMed ID: 14507304
[TBL] [Abstract][Full Text] [Related]
80. Standard Immunization of Mice, Rats, and Hamsters.
Greenfield EA
Cold Spring Harb Protoc; 2020 Mar; 2020(3):100297. PubMed ID: 32123014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
